Alumis (ALMS) Retained Earnings (2023 - 2025)
Alumis (ALMS) reported Retained Earnings of -$901.9 million for Q4 2025, down 2254790.0% year-over-year from N/an in Q4 2024, and down 385517.09% quarter-over-quarter from $234000.0 in Q3 2025.
Alumis (ALMS) Retained Earnings (2023 - 2025) Analysis & Trends
Alumis (ALMS) has 3 years of Retained Earnings data on file, last reported at -$901.9 million in Q4 2025.
- Retained Earnings for Q4 2025 came in at -$901.9 million, down 2254790.0% year-over-year; the trailing twelve-month figure through Dec 2025 was -$901.9 million (down 2254790.0% YoY), and the FY2025 annual result was -$901.9 million, down 2254790.0% from the prior year.
- Retained Earnings retreated to -$901.9 million in Q4 2025 per ALMS's latest filing, from $234000.0 in the prior quarter.
- Over five years, Retained Earnings peaked at $234000.0 in Q3 2025 and troughed at -$901.9 million in Q4 2025.
- A 3-year average of -$469.5 million and a median of -$517.2 million in 2024 frame the typical range for Retained Earnings.
- On a YoY basis, Retained Earnings climbed as much as 100.04% in 2025 and fell as far as 2254790.0% in 2025.
- A 3-year view of Retained Earnings shows it stood at -$364.3 million in 2023, then surged by 100.01% to $40000.0 in 2024, then sank by 2254790.0% to -$901.9 million in 2025.
- Business Quant data shows ALMS's Retained Earnings at -$901.9 million in Q4 2025, $234000.0 in Q3 2025, and -$698.2 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | -153.89 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -211.85 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.00 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 130.89 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -279.00 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -1.88 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 14.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -838.07 Mn |
| 10 | Alumis | 1.99 Bn | 1.90 Bn | - | -901.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -901.88 Mn |
| Sep 30, 2025 | 234,000.00 |
| Jun 30, 2025 | -698.20 Mn |
| Mar 31, 2025 | -757.51 Mn |
| Dec 31, 2024 | 40,000.00 |
| Sep 30, 2024 | -563.79 Mn |
| Jun 30, 2024 | -470.70 Mn |
| Dec 31, 2023 | -364.32 Mn |